Ccp Antibody Riga Igg
CD79a (B-Cell Marker) (rIGA/764) Antibody |
|||
| BNC701862-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Igg Antibody Laboratories manufactures the ccp antibody riga igg reagents distributed by Genprice. The Ccp Antibody Riga Igg reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igg antibody. Other Ccp products are available in stock. Specificity: Ccp Category: Antibody Group: Riga Igg
CD79a (B-Cell Marker) (rIGA/764) Antibody |
||
| Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), CF543 conjugate, Concentration: 0.1mg/mL |
||
CD79a (B-Cell Marker) (rIGA/764) Antibody |
||
| Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), CF405M conjugate, Concentration: 0.1mg/mL |
||
CD79a (B-Cell Marker) (rIGA/764) Antibody |
||
| Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), CF405M conjugate, Concentration: 0.1mg/mL |
||
CD79a (B-Cell Marker) (rIGA/764) Antibody |
||
| Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), CF555 conjugate, Concentration: 0.1mg/mL |
||
CD79a (B-Cell Marker) (rIGA/764) Antibody |
||
| Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), CF555 conjugate, Concentration: 0.1mg/mL |
||
CD79a (B-Cell Marker) (rIGA/764) Antibody |
||
| Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), CF660R conjugate, Concentration: 0.1mg/mL |
||
CD79a (B-Cell Marker) (rIGA/764) Antibody |
||
| Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), CF660R conjugate, Concentration: 0.1mg/mL |
||
CD79a (B-Cell Marker) (rIGA/764) Antibody |
||
| Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), APC conjugate, Concentration: 0.1mg/mL |
||
CD79a (B-Cell Marker) (rIGA/764) Antibody |
||
| Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), CF680R conjugate, Concentration: 0.1mg/mL |
||
CD79a (B-Cell Marker) (rIGA/764) Antibody |
||
| Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), CF680R conjugate, Concentration: 0.1mg/mL |
||
CD79a (B-Cell Marker) (rIGA/764) Antibody |
||
| Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), PerCP conjugate, Concentration: 0.1mg/mL |
||
CD79a (B-Cell Marker) (rIGA/764) Antibody |
||
| Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), RPE conjugate, Concentration: 0.1mg/mL |
||
CD79a (B-Cell Marker) (rIGA/764) Antibody |
|||
| BNCP1862-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), PerCP conjugate, Concentration: 0.1mg/mL |
|||
CD79a (B-Cell Marker) (rIGA/764) Antibody |
|||
| BNCR1862-250 | Biotium | 250uL | EUR 472.8 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), RPE conjugate, Concentration: 0.1mg/mL |
|||
CD79a (B-Cell Marker) (rIGA/764) Antibody |
|||
| BNUB1862-50 | Biotium | 50uL | EUR 486 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), 1mg/mL |
|||
CD79a (B-Cell Marker) (rIGA/764) Antibody |
|||
| BNCAP1862-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD79a (B-Cell Marker) (rIGA/764) Antibody |
|||
| BNCAP1862-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD79a (B-Cell Marker) (rIGA/764) Antibody |
|||
| BNCH1862-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD79a (B-Cell Marker) (rIGA/764) Antibody |
|||
| BNCH1862-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD79a (B-Cell Marker) (rIGA/764) Antibody |
|||
| BNC431862-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD79a (B-Cell Marker) (rIGA/764) Antibody |
|||
| BNC431862-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD79a (B-Cell Marker) (rIGA/764) Antibody |
|||
| BNC051862-100 | Biotium | 100uL | EUR 279.6 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD79a (B-Cell Marker) (rIGA/764) Antibody |
|||
| BNC051862-500 | Biotium | 500uL | EUR 654 |
|
Description: Primary antibody against CD79a (B-Cell Marker) (rIGA/764), CF405M conjugate, Concentration: 0.1mg/mL |
|||
human anti-human CCP IgG(111) |
|||
| E4A11C09-111 | EnoGene | 50ug | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
human anti-human CCP IgG(54) |
|||
| E4A11C09-54 | EnoGene | 50ug | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
human anti-human CCP IgG(F3M) |
|||
| E4A11C09-F3M | EnoGene | 50ug | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
human anti-human CCP IgG(K3N) |
|||
| E4A11C09-K3N | EnoGene | 100ug | EUR 995 |
human anti-human CCP IgG(S5N) |
|||
| E4A11C09-S5N | EnoGene | 100ug | EUR 995 |
human anti-human CCP IgG(T1K) |
|||
| E4A11C09-T1K | EnoGene | 100ug | EUR 995 |
human anti-human CCP IgG(E22M) |
|||
| E4A11C09-E22M | EnoGene | 50ug | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
CD79a (B-Cell Marker)(rIGA/764), 1mg/mL |
|||
| BNUM1862-50 | Biotium | 1uL | EUR 396 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD79a (B-Cell Marker) (rIGA/764), 0.2mg/mL |
|||
| BNUB1862-100 | Biotium | 100uL | EUR 225 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD79a (B-Cell Marker) (rIGA/764), 0.2mg/mL |
|||
| BNUB1862-500 | Biotium | 500uL | EUR 485 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Human CCP Antibody ELISA Kit |
|||
| DEIA1227 | Creative Diagnostics | 96T | EUR 1088.64 |
|
Description: culture supernatants, serum, plasma, tissues |
|||
CD79a (B-Cell Marker) (rIGA/764), CF568 conjugate, 0.1mg/mL |
|||
| BNC681862-100 | Biotium | 100uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD79a (B-Cell Marker) (rIGA/764), CF568 conjugate, 0.1mg/mL |
|||
| BNC681862-500 | Biotium | 500uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD79a (B-Cell Marker) (rIGA/764), CF594 conjugate, 0.1mg/mL |
|||
| BNC941862-100 | Biotium | 100uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD79a (B-Cell Marker) (rIGA/764), CF594 conjugate, 0.1mg/mL |
|||
| BNC941862-500 | Biotium | 500uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD79a (B-Cell Marker) (rIGA/764), CF647 conjugate, 0.1mg/mL |
|||
| BNC471862-100 | Biotium | 100uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
CD79a (B-Cell Marker) (rIGA/764), CF647 conjugate, 0.1mg/mL |
|||
| BNC471862-500 | Biotium | 500uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||